These results indicate that TRIB2 is a marker of poor prognosis in brain tumors and correlates with the expression of hypoxia-inducible factors, ectonucleotidases, and the A3AR gene involved in purinergic signaling in GB. The gene discussed is ADORA3; the disease is brain neoplasm.